NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer

All NewsMarch 26, 2026

NovoCure shares rise after PANOVA-4 data show higher disease control and survival signals in metastatic pancreatic cancer.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent